2023
|
Invention
|
Viral-vector recombinant vaccine against porcine epidemic diarrhoea. Described is a recombinant v... |
2022
|
Invention
|
Recombinant vaccine against covid-19 to produce cellular response in individuals with pre-existin... |
2021
|
Invention
|
Recombinant vaccine against covid-19 based on a paramyxovirus viral vector.
An active or inactiv... |
|
Invention
|
Recombinant vaccine against covid-19 based on a paramyxovirus viral vector. Described is a recomb... |
2020
|
Invention
|
Recombinant vaccine against covid-19 in a viral vector. A live or inactivated recombinant vaccine... |
2014
|
Invention
|
Recombinant inactivated viral vector vaccine.
A vaccine is described, comprising an inactivated ... |
|
Invention
|
Vaccine in a recombinant vector of avian adenovirus serotype 9. The invention relates to a recomb... |
2011
|
Invention
|
Recombinant vaccine against prrs in a viral vector. A live or inactivated recombinant vaccine is ... |
2009
|
Invention
|
Coccidiocide combination for veterinary use. A combination is described that has coccidiocidal ef... |
2008
|
Invention
|
Recombinant inactivated viral vector vaccine. A vaccine is described, comprising an inactivated v... |
|
Invention
|
Recombinant inactivated viral vector vaccine. A vaccine is described comprising an inactivated vi... |
2000
|
Invention
|
Avian infectious bronchitis virus serotype. Disclosed is an avian infectious bronchitis virus ser... |